S100A12 and irritable bowel syndrome: The present study, however, is the first testing the utility of serum S100A12 levels in discriminating IBD from IBS in adults, while at the same time examining serum S100A12 titers with respect to disease type (UC or CD) or activity, traditional markers of disease activity, patients' characteristics and treatment modalities.